Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Group Processes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00629239
What this trial is testing

Tolerability/Safety and Efficacy of Inhaled AZD4818 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca 65
Testing effectiveness (Phase 2)Study completedNCT02056665
What this trial is testing

Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome

Who this might be right for
Angelman Syndrome
Puerta de Hierro University Hospital 32
Not applicableLooking for participantsNCT07561957
What this trial is testing

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Who this might be right for
Chronic Kidney DiseaseProteinuriaBlood Pressure Control+5 more
St. James's Hospital, Ireland 80
Large-scale testing (Phase 3)Study completedNCT00677807
What this trial is testing

Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
COPD
Novartis 415
Testing effectiveness (Phase 2)Study completedNCT02284568
What this trial is testing

Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

Who this might be right for
Primary Progressive Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 374
Not applicableLooking for participantsNCT05400824
What this trial is testing

Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)

Who this might be right for
Infectious DiseaseCardiovascular DiseasesGeneral Population+1 more
Institut National de la Santé Et de la Recherche Médicale, France 2,000
Not applicableStudy completedNCT00444444
What this trial is testing

Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)

Who this might be right for
Pancreatitis
Asan Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT02465944
What this trial is testing

A Pilot Study of FFP104 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Fast Forward Pharmaceuticals 24
Not applicableStudy completedNCT03393663
What this trial is testing

Chronic Kidney Disease: Determinants of Progression and Cardiovascular Risk

Who this might be right for
Chronic Kidney Diseases
University of Sao Paulo 454
Not applicableEnded earlyNCT06077734
What this trial is testing

Muscle Stem Cell Quality in Atrophy

Who this might be right for
Muscle WeaknessAtrophy, MuscleCachexia+3 more
Maastricht University Medical Center 7
Not applicableLooking for participantsNCT07770932
What this trial is testing

Deep Subgluteal Block vs PENG Combined With LFCN Block for Analgesia After Hip Arthroplasty

Who this might be right for
Postoperative Pain
Medipol University 60
Not applicableStudy completedNCT01780298
What this trial is testing

Chronic Obstructive Pulmonary Disease (COPD) Biomarker Identification Study

Who this might be right for
COPD
Philip Morris Products S.A. 252
Early research (Phase 1)Looking for participantsNCT07605845
What this trial is testing

Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Gliknik Inc. 42
Not applicableLooking for participantsNCT05726825
What this trial is testing

Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock

Who this might be right for
Septic Shock
Hannover Medical School 274
Not applicableStudy completedNCT06267716
What this trial is testing

Pericapsular Nerve Block and Iliopsoas Fascial Plane Block in Hip Surgery

Who this might be right for
Hip FracturesPeripheral Nerve Block
Haseki Training and Research Hospital 60
Post-approval studies (Phase 4)Study completedNCT01489124
What this trial is testing

The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated Pneumonia

Who this might be right for
Ventilator-Associated Pneumonia
Sutep Jaruratanasirikul 9
Early research (Phase 1)Study completedNCT01445782
What this trial is testing

AZD2115 Multiple Ascending Dose Study

Who this might be right for
Healthy
AstraZeneca 32
Not applicableUnknownNCT05917925
What this trial is testing

Evaluation of the Effect of a Food Supplement Based on Hydrolyzed Collagen on Joint Function.

Who this might be right for
Pain, AcutePain, ChronicKnee Osteoarthritis+1 more
Francisco Javier Martínez Noguera 80
Not applicableStudy completedNCT05866276
What this trial is testing

To Determine the Accuracy of SCreening for Occult REnal Disease (SCORED) Questionnaire for CKD Risk Among Asian Patients

Who this might be right for
Chronic Kidney Disease
AstraZeneca 1,426
Not applicableEnrolling By InvitationNCT04848090
What this trial is testing

Genome Sequencing in the Intensive Care Unit Population

Who this might be right for
Infant, Newborn, DiseaseGenetic Disease
Jerry Vockley, MD, PhD 400
Next Page